See All Slides - tctmd.com

Slides

Presentation TCT 2019

First Experience With FDA-Approved Orsiro in the USA

Presenter: Farouc Jaffer

September 26, 2019

Presentation TCT 2019

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Presenter: Alexandre Abizaid

September 26, 2019

Presentation TCT 2019

Predictions for a Changing Future in AS Management: Revised Guidelines, Expanded TAVR Indications, Shifting Referral Practices, and Earlier Treatment Decisions

Presenter: Philippe Genereux

September 26, 2019

Presentation TCT 2019

Why SEB Should Be Safer: Insights From Preclinical Study

Presenter: Aloke Finn

September 26, 2019

Presentation TCT 2019

Delivering Evidence

Presenter: James Hermiller

September 26, 2019

Presentation TCT 2019

Concept of MagicTouch

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

Case Presentation: Low-Risk AS

Presenter: Amisha Patel

September 26, 2019

Presentation TCT 2019

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Presenter: Usman Baber

September 26, 2019

Presentation TCT 2019

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

Presenter: Ken Kozuma

September 26, 2019

Advertisement

Slides

First Experience With FDA-Approved Orsiro in the USA

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Predictions for a Changing Future in AS Management: Revised Guidelines, Expanded TAVR Indications, Shifting Referral Practices, and Earlier Treatment Decisions

Why SEB Should Be Safer: Insights From Preclinical Study

Delivering Evidence

Concept of MagicTouch

Case Presentation: Low-Risk AS

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content